Engineered Probiotic-Based Biomaterials for Inflammatory Bowel Disease Treatment DOI Creative Commons

Guangze Sang,

Bo Wang, Yujie Xie

и другие.

Theranostics, Год журнала: 2025, Номер 15(8), С. 3289 - 3315

Опубликована: Фев. 18, 2025

Inflammatory bowel disease (IBD) is a chronic condition affecting the intestines, marked by immune-mediated inflammation. This known for its recurrent nature and challenges it presents in treatment. Recently, probiotic have gained attention as promising alternative to traditional small molecular drugs monoclonal antibody chemotherapies IBD. Probiotic, recognized "living" therapeutic agent, offers targeted treatment with minimal side effects flexibility biological modifications, making them highly effective IBD management. comprehensive review latest advancements engineering probiotic-based materials, ranging from basic mechanisms modification techniques used It delves deep into how produces intestinal environment discusses various strategies enhance probiotic's efficacy, including genetic modifications formulation improvements. Additionally, addresses challenges, practical application conditions, future research directions of therapies treatment, providing insights their feasibility potential clinical implications.

Язык: Английский

Prebiotics empower probiotics with gastrointestinal stress resistance for colon-targeted release to synergistically alleviate colitis DOI

Haihua Ji,

Xiao-Chen Yan, Li Zhang

и другие.

Journal of Controlled Release, Год журнала: 2025, Номер 380, С. 297 - 316

Опубликована: Фев. 7, 2025

Язык: Английский

Процитировано

2

The Gut Microbiota‐Xanthurenic Acid‐Aromatic Hydrocarbon Receptor Axis Mediates the Anticolitic Effects of Trilobatin DOI Creative Commons
Xiaoyu Wu,

Jiajia Wei,

Ran Wang

и другие.

Advanced Science, Год журнала: 2025, Номер unknown

Опубликована: Янв. 21, 2025

Abstract Current treatments for ulcerative colitis (UC) remain limited, highlighting the need novel therapeutic strategies. Trilobatin (TLB), a naturally derived food additive, exhibits potential anti‐inflammatory properties. In this study, dextran sulfate sodium (DSS)‐induced animal model is used to investigate effects of TLB on UC. It found significantly alleviates DSS‐induced UC in mice, as evidenced by reduction disease activity index, an increase colon length, improvement histopathological lesions. Furthermore, treatment results decrease proinflammatory cytokines and cytokines. mitigates modulating intestinal microbiota, particularly Akkermansia , which enhances tryptophan metabolism upregulates production xanthurenic acid (XANA). To confirm role TLB‐induced microbiota changes, experiments are performed with pseudogerm‐free mice fecal transplantation. also identified XANA key metabolite that mediates TLB's protective effects. Both markedly activate aromatic hydrocarbon receptor (AhR). Administration AhR antagonist abrogates their effects, thereby confirming involvement underlying mechanism. conclusion, study reveals mechanism through correcting imbalances, regulating metabolism, enhancing production, activating AhR.

Язык: Английский

Процитировано

0

The therapeutic potential of nanoencapsulated anti-inflammatory drugs delivered to the gut DOI Creative Commons
Wenhao Li, Lili Qiu, Xiaoyu Wang

и другие.

Nanomedicine, Год журнала: 2025, Номер unknown, С. 1 - 3

Опубликована: Фев. 5, 2025

Язык: Английский

Процитировано

0

Microbially synthesized nanomaterials: Advances and applications in biomedicine DOI Creative Commons
Junjie Pan, Hong Qian, Ya‐Yen Sun

и другие.

Precision medicine and engineering., Год журнала: 2025, Номер unknown, С. 100019 - 100019

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Oral Antioxidant-Engineered Probiotics for the Treatment of Radiation-Induced Colitis DOI
Rong Sun, Shuaiwen Li, Zihui Chen

и другие.

ACS Applied Materials & Interfaces, Год журнала: 2025, Номер unknown

Опубликована: Фев. 10, 2025

Radiation colitis is an inflammatory response induced by damage to colonic tissue from radiation therapy that primarily affects patients undergoing abdominal or pelvic treatments. In this study, we designed a selenium-loaded probiotic (EcN-Se@SA) encapsulated in sodium alginate gel for the oral treatment of colitis. Selenium nanoparticles (Se NPs) exhibit antioxidant, anti-inflammatory, ferroptosis, and repair-promoting properties. To enhance therapeutic efficacy Se NPs radiation-induced colitis, combined with Escherichia coli Nissle 1917 them hydrogel. The resulting EcN-Se@SA formulation not only withstands gastric acid intestinal fluids but also remains colon cecum extended periods. Oral administration attenuates X-ray-induced mice through its antioxidant anti-inflammatory effects, macrophage reprogramming, inhibition ferroptosis histiocytes. This work introduces promising candidate

Язык: Английский

Процитировано

0

Engineered Probiotic-Based Biomaterials for Inflammatory Bowel Disease Treatment DOI Creative Commons

Guangze Sang,

Bo Wang, Yujie Xie

и другие.

Theranostics, Год журнала: 2025, Номер 15(8), С. 3289 - 3315

Опубликована: Фев. 18, 2025

Inflammatory bowel disease (IBD) is a chronic condition affecting the intestines, marked by immune-mediated inflammation. This known for its recurrent nature and challenges it presents in treatment. Recently, probiotic have gained attention as promising alternative to traditional small molecular drugs monoclonal antibody chemotherapies IBD. Probiotic, recognized "living" therapeutic agent, offers targeted treatment with minimal side effects flexibility biological modifications, making them highly effective IBD management. comprehensive review latest advancements engineering probiotic-based materials, ranging from basic mechanisms modification techniques used It delves deep into how produces intestinal environment discusses various strategies enhance probiotic's efficacy, including genetic modifications formulation improvements. Additionally, addresses challenges, practical application conditions, future research directions of therapies treatment, providing insights their feasibility potential clinical implications.

Язык: Английский

Процитировано

0